Refined Sesame Oil for Pharmaceutical Applications
TRADER PARTNERS LTD sources and supplies refined sesame oil (Sesamum indicum L.), Master Art. No. 84200, manufactured by Henry Lamotte Oils GmbH, Bremen. The batch Certificate of Analysis records compliance with the current European Pharmacopoeia (Ph. Eur.) and British Pharmacopoeia (BP), with a full specification, Safety Data Sheet and pharmaceutical product statement available on request.
Product overview
This page covers one specific traded material: refined sesame oil under the manufacturer's Master Article No. 84200. The technical content below is taken directly from the manufacturer's product specification, batch Certificate of Analysis, Safety Data Sheet and statement for pharmaceutical products. Where broader pharmaceutical context is given, it is clearly separated from the document-supported product facts.
TRADER PARTNERS LTD is a UK-registered international sourcing and procurement company. We do not manufacture the oil; we source it, handle documentation, export and delivery, and act as the buyer's procurement counterparty. We do not claim an official or exclusive distributorship for the manufacturer.
| Attribute | Value |
|---|---|
| Product | Sesame Oil, Refined |
| Botanical source | Sesamum indicum L. |
| Master Article No. | 84200 |
| CAS No. | 8008-74-0 |
| EC No. | 232-370-6 |
| Composition | 100 % sesame oil |
| Manufacturer named in documentation | Henry Lamotte Oils GmbH, Merkurstraße 47, 28197 Bremen, Germany |
| Sourcing and supply | TRADER PARTNERS LTD (UK-registered, company no. 16575073) |
Pharmacopoeial evidence
The supplied batch Certificate of Analysis records compliance with the current Ph. Eur. and current BP, with triglyceride distribution analysed according to Ph. Eur.
Documentation set
Product specification, batch-specific Certificate of Analysis, Safety Data Sheet and statement for pharmaceutical products.
Batch-level confirmation
Pharmacopoeial compliance and measured values are recorded per batch — always confirm documentation for the individual batch offered against your order.
Technical specification
Standard specification for Master Art. No. 84200 (manufacturer document version 6). The figures below are specification limits, not measured values for any individual batch.
| Chemical data | min. | max. |
|---|---|---|
| Specific gravity (20 °C) | 0.915 | 0.923 |
| Refractive index (20 °C) | 1.470 | 1.476 |
| Acid value | — | 0.3 |
| Iodine value | 103 | 118 |
| Saponification value | 186 | 195 |
| Unsaponifiable matter | — | 2.0 % |
Fatty acid composition
Documented fatty acid ranges and maximum limits from the same standard specification. A dash indicates that the specification states a maximum only.
| Fatty acid | min. | max. |
|---|---|---|
| Palmitic acid (C16:0) | 7.9 % | 12.0 % |
| Stearic acid (C18:0) | 3.9 % | 7.0 % |
| Oleic acid (C18:1) | 35.9 % | 44.7 % |
| Linoleic acid (C18:2) | 36.0 % | 47.9 % |
| Linolenic acid (C18:3) | — | 0.6 % |
| Arachidic acid (C20:0) | — | 0.9 % |
| Eicosenoic acid (C20:1) | — | 0.5 % |
| Behenic acid (C22:0) | — | 0.4 % |
| Erucic acid (C22:1) | — | 0.1 % |
Example batch Certificate of Analysis
Certificates of Analysis carry the actual measured values for an individual lot. The extract below is taken from one supplied Certificate of Analysis and is shown purely as an example of the data available.
Example / supplied batch documentation — not guaranteed values for future batches.
| Inspection feature | Recorded value |
|---|---|
| Lot No. | Q10010371 |
| Date of manufacturing | 13.04.2026 |
| Best-before date | 13.12.2027 |
| Acid value | 0.06 |
| Water | 0.01 % |
| Unsaponifiable matter | 1.2 % |
| Specific gravity (20 °C) | 0.920 |
| Refractive index (20 °C) | 1.472 |
| Complies with the current Ph. Eur. | Yes |
| Complies with the current BP | Yes |
Manufacturer statement for pharmaceutical products
The manufacturer issues a consolidated statement for pharmaceutical products covering the topics most frequently raised by pharmaceutical quality and regulatory affairs teams. The summary below reproduces the substance of that document; it consists of manufacturer declarations, not independent certification.
| Topic | Documented statement |
|---|---|
| Origin | Pure vegetable origin; composition 100 % sesame oil (Sesamum indicum L.). |
| BSE / TSE | Stated to have no contact with animal materials during production, storage or transport, and therefore not affected by the guidance in chapter 5.2.8 of the European Pharmacopoeia. |
| Contaminants | Stated to comply with Regulation (EC) No 2023/915 as amended (including dioxins, dioxin-like and non-dioxin-like PCBs, erucic acid, glycidyl esters and 3-MCPD, PAH, melamine, heavy metals). |
| Gluten | Risk-assessment based confirmation of gluten-free status (≤ 20 mg/kg). |
| GMO | Not subject to labelling under Regulations (EC) No 1829/2003 and 1830/2003. |
| Latex | No latex added during production. |
| Microbiology | aw value below 0.6; acceptance criteria for non-sterile substances for pharmaceutical use stated (see below). |
| Mycotoxins & aflatoxins | Risk-assessment based declaration of accordance with the German 'Aflatoxin-VerbotsV' limits for pharmaceutical products. |
| Nanomaterials | Not produced using nanotechnology per Regulation (EC) No 1169/2011; no nanomaterials added. |
| Nitrosamines | Assumed absent on the basis of product-related properties (no nitrogen-containing compounds). |
| Palm oil | No palm oil or palm-oil derivatives used. |
| Pesticides | Stated to comply with Regulation (EC) No 396/2005 as amended. |
| Ionising radiation | Not treated with ionising radiation. |
| Residual solvents | Where solvent extraction is used, refining reduces residues to meet Directive 2009/32/EC, the European Pharmacopoeia (CPMP/ICH/82260/06) and USP <467> requirements. |
| Vegan | No ingredients of animal origin or derivatives used in raw materials, input materials or additives. |
| Animal testing | Confirmed not subject to animal testing by or on behalf of the manufacturer since 1 December 1985. |
Microbiological acceptance criteria
The statement notes that a microbiological risk can be excluded because the product has a water activity (aw) below 0.6, and confirms the following acceptance criteria for the microbiological quality of non-sterile substances for pharmaceutical use:
| Test | Acceptance criterion |
|---|---|
| Aerobic total microbial count | max. 1,000 CFU/g |
| Total count yeasts and moulds | max. 100 CFU/g |
Safety data summary
Summarised from the manufacturer's Safety Data Sheet issued under Regulation (EC) No 1907/2006 (product code HL102, revision 1.8). This is a summary only — buyers must consult the current Safety Data Sheet supplied with their order for full handling, exposure-control and disposal information.
| Property | Information per supplied SDS |
|---|---|
| Composition | Sesame oil 99–100 % (CAS 8008-74-0, EC 232-370-6) |
| CLP classification | Not classified as hazardous under Regulation (EC) No 1272/2008 |
| Physical state | Liquid |
| Colour | Light yellow to brownish |
| Odour | Characteristic |
| Flash point | > 200 °C |
| Water solubility | Insoluble in water |
| Chemical stability | Stable under storage at normal ambient temperatures |
| Biodegradability | Readily biodegradable according to OECD criteria |
Transport classification
According to the supplied current Safety Data Sheet, the material is recorded as not being a dangerous good within the meaning of the ADR/RID (road and rail), ADN (inland waterway), IMDG (marine) and ICAO-TI / IATA-DGR (air) transport regulations. This reflects the manufacturer's SDS entries at the revision we hold and is not independent legal or dangerous-goods advice; the classification applicable to your shipment should be confirmed against the current SDS version at the time of despatch.
Storage
The product specification recommends storage protected from light, not above room temperature, in tightly sealed containers, noting that the addition of nitrogen is beneficial and that opened containers should be used immediately. The Certificate of Analysis also notes that natural oil substances and waxes can settle during storage and form slight sedimentation at the bottom of the packing unit, which should be taken into account when emptying containers.
Pharmaceutical context — general industry background
Refined vegetable oils are long-established pharmaceutical excipients. In general formulation practice they are used as lipophilic vehicles and carriers for poorly water-soluble active substances, as the oil phase of emulsions and semi-solid preparations, and as diluents in certain oral and topical dosage forms. Sesame oil is the subject of monographs in the European Pharmacopoeia and the British Pharmacopoeia, which is why buyers routinely specify Ph. Eur. or BP compliance in their material specifications.
That context is general industry and pharmacopoeial background. It is not a statement about the suitability of Master Art. No. 84200 for any specific dosage form, administration route or finished medicinal product. The manufacturer documentation we hold describes the material's identity, specification, batch analysis and quality declarations; it does not qualify the material for a particular finished pharmaceutical application, and it does not state sterile, injectable-grade or GMP-certified status.
Determining suitability — including the applicable pharmacopoeial grade, supplier qualification, and any additional testing required under your quality system — remains the responsibility of the purchasing manufacturer's formulation, quality and regulatory functions. We support that assessment by supplying the underlying documentation early in the enquiry, before commitment.
Documentation available on request
Product specification
Standard specification for Master Art. No. 84200 with chemical data and fatty acid composition.
Certificate of Analysis
Batch-specific COA with measured values, identity and purity checks, and recorded pharmacopoeial compliance.
Safety Data Sheet
Current manufacturer SDS under Regulation (EC) No 1907/2006, including transport and handling sections.
Statement for pharmaceutical products
Consolidated manufacturer declarations covering BSE/TSE, contaminants, gluten, GMO, latex, microbiology, mycotoxins, nanomaterials, palm oil, pesticides, radiation, residual solvents and vegan status.
Batch-related origin information
Country of origin can be specified batch-related; subject to availability at the time of shipment.
Documentation is issued to identified business buyers on request rather than published for open download, so that the version supplied always matches the batch and order under discussion.
Request pharmaceutical sesame oil supply
To quote accurately, please include the following in your enquiry: required quantity, destination country, intended industry or application, the required specification or pharmacopoeia (Ph. Eur., BP or both), packaging requirement, required delivery date, and the documentation set you need with the shipment.
Buyer questions
Capabilities
Related procurement capability
How this material fits into our wider healthcare and pharmaceutical sourcing work.
APIs, excipients and intermediates sourced for regulated manufacturers.
Cross-border procurement, documentation and delivery.
Multi-region supplier identification and qualification.
How we qualify and document every manufacturer we buy from.
Procurement support for laboratory and analytical operations.
Send a specification and receive a documented quotation.
Company credentials
Verified UK-registered trading company
UK Registered
Company No. 16575073
Registered Office
13 Ashbourne Parade, London, England, W5 3QS
Phone
+44 20 8987 8083Compliance & Quality Assurance: We verify manufacturer certification and regulatory documentation for each product and destination market, and supply the traceability records with every shipment. Certifications such as CE, UKCA, FDA and ISO 13485 are held by the manufacturer, not by TRADER PARTNERS LTD. Read more on our Compliance and Quality Assurance pages.